![](/img/cover-not-exists.png)
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval
Deniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, Ali-Nuri Hünerlitürkoglu, Michael Gonnermann, Thomas Kegel, Harald Scheiber, Wolf-Oliver Jordan, Iris Burkholder, Lenka Kellermann, Ralf-Dieter HofheinVolume:
139
Language:
english
DOI:
10.1007/s00432-012-1335-7
Date:
February, 2013
File:
PDF, 452 KB
english, 2013